Citations

Clear

11 citation(s) found for "Smith, Hugh".

A long-term image-derived AI-based risk model for primary prevention of breast cancer in individuals at high risk
Eriksson, Mikael , Czene, K, Scott, C, Stoddard, Shawn, Smith, Hugh, Hall, Per , Vachon, C, Scott, Christopher G. , Vachon, Celine M. , Czene, Kamila , Czene, Kamila , Scott, Christopher , Vachon, Celine M. , Hall, Per N , Eriksson, Mikael , Stoddard, Shawn M.

Mayo Clinic

Science Translational Medicine | May 20, 2026 | Volume: 18 | Issue: 850 | Pages: No page available

10.1126/scitranslmed.ady7414 | PMID 42160452 Get It

Image-derived artificial intelligence (AI) risk models have shown promise in short-term risk assessment for improving breast cancer (BC) screening. No image-derived long-term AI risk model for primary prevention has been developed and externally validated. Individuals aged 31 to 94 years were recruited between 2010 and 2020 in two population-based case cohorts (Olmsted County, Minnesota, US, and KARMA, Sweden) and one hospital-based case-control study (EMBED, Atlanta, US). Median follow-up in the case cohorts was 10 years, with BCs diagnosed through June 2022. Additional validation was performed in EMBED with 3-year follow-up. An AI risk model was developed in Sweden, and we report independent validation in Olmsted/KARMA/EMBED. Absolute 10-year risks were estimated at study entry. Time-dependent discriminatory performance [AUC( t )] and expected-to-observed events (E/O) were estimated. Comparisons were performed with clinical risk tools and the image-based Mirai tool. Across Olmsted/KARMA, 8696 individuals (mean age, 54.4±10.6) and 1633 individuals with incident BC (mean age, 57.0±10.6) were included. Average 10-year risks were 3.83 and 3.14%, and E/O ratios were 0.99 and 0.99. Ten-year AUC( t ) for invasive BCs were 0.72 in Olmsted and 0.72 in KARMA. Similar discriminatory results were observed in EMBED. Our AI risk tool performed significantly better than Mirai in Olmsted/KARMA/EMBED. In KARMA, in the top 10% of high-risk individuals, the AI risk tool predicted 33% of BCs compared with 23%/20%/24% predicted by Tyrer-Cuzick-v8/BCSC-v3/Mirai (all P < 0.01). The 10-year image-derived AI risk model showed significantly higher performance than clinical risk models and Mirai in diverse populations, supporting its clinical potential for primary prevention.
Hemodynamic Progression of Adult Valvular Aortic Stenosis
Amy, SW, Holmes, David R. , Smith, Hugh C., Connolly, Daniel C., Hynes, Janey, Ilstrup, Duane M., Danielson, Gordon K., Ng, Amy S.H.

Mayo Clinic

Catheterization and Cardiovascular Diagnosis | December 17, 2025 | Volume: 12 | Issue: 3 | Pages: 145-150

10.1002/j.1097-0304.1986.tb00002.x Get It

Hemodynamic progression of valvular aortic stenosis was studied in 54 patients who had serial cardiac catheterizations. There were 47 men and 7 women with a mean age of 61.2 years. The time interval between studies was 4.4 years (range, 0.4‐12.2). Associated coronary artery disease was present in 37 patients (69%). The initial mean aortic valve area (Hakki's formula) was 1.26 cm 2 (range, 0.66‐2.85), and the aortic valve area at last follow‐up was 0.77 cm 2 (range, 0.29‐1.95), with mean reduction of 0.49 cm 2 . The mean peak systolic gradient increased from 23.3 ± 15.1 mm Hg at initial study to 52.6 ± 27.5 mm Hg at last study, a mean increase of 29.3 ± 23.6 mm Hg. Patients with no or mild left ventricular impairment and no or mild coronary artery disease are more likely to have progression than patients with more severe left ventricular impairment or coronary artery disease (P < 0.05). Aortic valve replacement for progressive aortic stenosis was required at a later date after coronary artery bypass grafting in a small group of nine patients. In this small group, there was a high intraoperative mortality of 33%.
Spinal versus general anaesthesia in contemporary primary total knee arthroplasties
Owen, Aaron R. , Amundson, Adam W. , Duncan, Christopher M. , Smith, Hugh M. , Johnson, Rebecca L. , Taunton, Michael J. , Pagnano, Mark W. , Berry, Daniel J. , Larson, Dirk R. , Johnson, Rebecca L , Taunton, Michael J , Berry, Daniel J , Abdel, Matthew P.

Mayo Clinic

The Bone & Joint Journal | November 1, 2022 | Volume: 104-B | Issue: 11 | Pages: 1209-1214

10.1302/0301-620x.104b11.bjj-2022-0469.r2 | PMID 36317343 Get It

Aims Spinal anaesthesia has seen increased use in contemporary primary total knee arthroplasties (TKAs). However, controversy exists about the benefits of spinal in comparison to general anaesthesia in primary TKAs. This study aimed to investigate the pain control, length of stay (LOS), and complications associated with spinal versus general anaesthesia in primary TKAs from a single, high-volume academic centre. Methods We retrospectively identified 17,690 primary TKAs (13,297 patients) from 2001 to 2016 using our institutional total joint registry, where 52% had general anaesthesia and 48% had spinal anaesthesia. Baseline characteristics were similar between cohorts with a mean age of 68 years (SD 10), 58% female (n = 7,669), and mean BMI of 32 kg/m2 (SD 7). Pain was evaluated using oral morphine equivalents (OMEs) and numerical pain rating scale (NPRS) data. Complications including 30- and 90-day readmissions were studied. Data were analyzed using an inverse probability of treatment weighted model based on propensity score that included many patient and surgical factors. Mean follow-up was seven years (2 to 18). Results Patients treated with spinal anaesthesia required fewer postoperative OMEs (p < 0.001) and had lower NPRS scores (p < 0.001). Spinal anaesthesia also had fewer cases of altered mental status (AMS; odds ratio (OR) 1.3; p = 0.044), as well as 30-day (OR 1.4; p < 0.001) and 90-day readmissions (OR 1.5; p < 0.001). General anaesthesia was associated with increased risk of any revision (OR 1.2; p = 0.021) and any reoperation (1.3; p < 0.001). Conclusion In the largest single institutional report to date, we found that spinal anaesthesia was associated with significantly lower OME use, lower risk of AMS, and lower overall 30- and 90-day readmissions following primary TKAs. Additionally, spinal anaesthesia was associated with reduced risk of any revision and any reoperation after accounting for numerous patient and operative factors. When possible and safe, spinal anaesthesia should be considered in primary TKAs. Cite this article: Bone Joint J 2022;104-B(11):1209–1214.
Spinal Compared with General Anesthesia in Contemporary Primary Total Hip Arthroplasties
Owen, Aaron R. , Amundson, Adam W. , Fruth, Kristin M. , Duncan, Christopher M. , Smith, Hugh M. , Johnson, Rebecca L. , Taunton, Michael J. , Pagnano, Mark W. , Berry, Daniel J. , Abdel, Matthew P. , Abdel, Matthew P , Johnson, Rebecca L , Taunton, Michael J , Berry, Daniel J , Fruth, Kristin M

Mayo Clinic

Journal of Bone and Joint Surgery | June 21, 2022 | Volume: 104 | Issue: 17 | Pages: 1542-1547

10.2106/jbjs.22.00280 | PMID 35726967 Get It

Background: The specific advantages of spinal anesthesia compared with general anesthesia for primary total hip arthroplasty (THA) remains unknown. Therefore, this study aimed to investigate the pain control, length of stay, and postoperative outcomes associated with spinal anesthesia compared with general anesthesia in a large cohort of primary THAs from a single, high-volume academic institution. Methods: We retrospectively identified 13,730 primary THAs (11,319 patients) from 2001 to 2016 using our total joint registry. Of these cases, 58% had general anesthesia and 42% had spinal anesthesia. The demographic characteristics were similar between groups, with mean age of 64 years, 51% female, and mean body mass index (BMI) of 31 kg/m 2 . Data were analyzed using an inverse probability of treatment weighted model based on a propensity score that accounted for numerous patient and operative factors. The mean follow-up was 6 years. Results: Patients treated with spinal anesthesia had lower Numeric Pain Rating Scale (NPRS) scores (p < 0.001) and required fewer postoperative oral morphine equivalents (OMEs) at all time points evaluated (p < 0.001). Patients treated with spinal anesthesia also had shorter hospital length of stay (p = 0.02), fewer altered mental status events (odds ratio [OR], 0.7; p = 0.02), and fewer intensive care unit (ICU) admissions (OR, 0.7; p = 0.01). There was no difference in the incidence of deep vein thrombosis (p = 0.8), pulmonary embolism (p = 0.4), 30-day readmissions (p = 0.17), 90-day readmissions (p = 0.18), all-cause revisions (p = 0.17), or all-cause reoperations (p = 0.14). Conclusions: In this large, single-institution study, we found that spinal anesthesia was associated with reduced pain scores and OME use postoperatively. Furthermore, spinal anesthesia resulted in fewer altered mental status events and ICU admissions. These data favor the use of spinal anesthesia in primary THAs. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
More Predictable Return of Motor Function with Mepivacaine Versus Bupivacaine Spinal Anesthetic in Total Hip and Total Knee Arthroplasty
Wyles, Cody C. , Pagnano, Mark W. , Trousdale, Robert T. , Sierra, Rafael J. , Taunton, Michael J. , Perry, Kevin I. , Larson, Dirk R. , Amundson, Adam W. , Smith, Hugh M. , Duncan, Christopher M. , Abdel, Matthew P , Sierra, Rafael J , Larson, Dirk , Taunton, Michael J , Wyles, Cody C , Abdel, Matthew P.

Mayo Clinic

Journal of Bone and Joint Surgery | August 26, 2020 | Volume: 102 | Issue: 18 | Pages: 1609-1615

10.2106/jbjs.20.00231 | PMID 32960532 Get It

Background: Spinal anesthesia provides several benefits for patients undergoing total hip arthroplasty (THA) and total knee arthroplasty (TKA), but historically comes at the cost of slow and unpredictable return of lower-extremity motor function related to the use of long-acting local anesthetics. In this prospective, double-blinded, randomized clinical trial we sought to determine if an alternative local anesthetic, mepivacaine, would allow more consistent return of motor function compared with low-dose bupivacaine spinal anesthesia during primary THA and TKA. Methods: This trial was conducted at a single academic institution. Prior to trial initiation an internal pilot study determined that 154 patients were required to achieve 80% power. Patients were randomized in a 1:1 fashion with use of advanced computerized stratification based on procedure, age group, sex, and body mass index. Following the surgical procedure, motor function was assessed every 15 minutes in the nonoperative lower extremity according to the Bromage scale and discontinued once Bromage 0 was achieved (spontaneous movement at hip, knee, and ankle). Results: Return of lower-extremity function was more predictable in patients who received mepivacaine than in those who received low-dose bupivacaine. Among patients who received mepivacaine, 1% achieved motor function return beyond 5 hours compared with 11% of patients who received bupivacaine (p = 0.013). The mean time to return of lower-extremity motor function was 26 minutes quicker in patients who received mepivacaine (185 minutes; 95% confidence interval, 174 to 196 minutes) compared with low-dose bupivacaine (210 minutes; 95% confidence interval, 193 to 228 minutes) (p = 0.016). There were no significant differences in safety outcomes including pain scores, time to participation in physical therapy, incidence of orthostatic hypotension, urinary retention, or transient neurologic symptoms in patients receiving mepivacaine compared with low-dose bupivacaine. Conclusions: In patients undergoing primary THA and TKA, spinal anesthesia with mepivacaine allowed more consistent return of lower-extremity motor function compared with low-dose bupivacaine, without a concomitant increase in complications potentially associated with spinal anesthetics. This is particularly of value in an era of short-stay and outpatient surgical procedures. Level of Evidence: Therapeutic Level I . See Instructions for Authors for a complete description of levels of evidence.
Ultrasound-Assisted Combined Spinal-Epidural Anesthesia for Cesarean Delivery in a Parturient With Currarino Triad: A Case Report
Kenevan, Melissa R., Smith, Hugh M. , Olsen, David A. , Kenevan, Melissa R., Sharpe, Emily E.

Mayo Clinic

A&A Practice | December 20, 2018 | Volume: 12 | Issue: 11 | Pages: 393-395

10.1213/xaa.0000000000000941 | PMID 31162165 Get It

Currarino triad is a rare hereditary condition characterized by anorectal malformation, sacral dysgenesis, and a presacral mass. Neuraxial anesthetic techniques pose increased risks to patients with spinal malformations. Ultrasound imaging improves accuracy of intervertebral level identification compared to clinical estimation. We present the case of a parturient with Currarino triad and a low conus medullaris undergoing cesarean delivery where preprocedural magnetic resonance imaging and ultrasound imaging allowed for successful combined spinal-epidural anesthesia to be performed. Despite these measures, however, the patient did develop a high spinal and temporary postoperative dizziness.
Interspace between Popliteal Artery and posterior Capsule of the Knee (IPACK) Injectate Spread: A Cadaver Study
Niesen, Adam D. , Johnson, Christopher , Stoike, David E., Smith, Hugh M. , Jacob, Adam K. , Amundson, Adam W. , Pawlina, Wojciech, Martin, David P., Harris, David J. , Johnson, Christopher S , Harris, David J.

Mayo Clinic

Journal of Ultrasound in Medicine | September 19, 2018 | Volume: 38 | Issue: 3 | Pages: 741-745

10.1002/jum.14761 | PMID 30232819 Get It

Objectives Local anesthetic injection into the interspace between the popliteal artery and the posterior capsule of the knee (IPACK) has the potential to provide motor‐sparing analgesia to the posterior knee after total knee arthroplasty. The primary objective of this cadaveric study was to evaluate injectate spread to relevant anatomic structures with IPACK injection. Methods After receipt of Institutional Review Board Biospecimen Subcommittee approval, IPACK injection was performed on fresh‐frozen cadavers. The popliteal fossa in each specimen was dissected and examined for injectate spread. Results Ten fresh‐frozen cadaver knees were included in the study. Injectate was observed to spread in the popliteal fossa at a mean ± SD of 6.1 ± 0.7 cm in the medial‐lateral dimension and 10.1 ± 3.2 cm in the proximal‐distal dimension. No injectate was noted to be in contact with the proximal segment of the sciatic nerve, but 3 specimens showed injectate spread to the tibial nerve. In 3 specimens, the injectate showed possible contact with the common peroneal nerve. The middle genicular artery was consistently surrounded by injectate. Conclusions This cadaver study of IPACK injection demonstrated spread throughout the popliteal fossa without proximal sciatic involvement. However, the potential for injectate to spread to the tibial or common peroneal nerve was demonstrated. Consistent surrounding of the middle genicular artery with injectate suggests a potential mechanism of analgesia for the IPACK block, due to the predictable relationship between articular sensory nerves and this artery. Further study is needed to determine the ideal site of IPACK injection.
Interscalene Brachial Plexus Block
Amundson, Adam W. , Smith, Hugh M.

Mayo Clinic

Anesthesiology | August 24, 2018 | Volume: 129 | Issue: 6 | Pages: 1166-1166

10.1097/aln.0000000000002410 | PMID 30142089 Get It

Clinical implications of de Barsy syndrome
Warner, Lindsay L. , Olsen, David A. , Smith, Hugh M.

Mayo Clinic

Pediatric Anesthesia | November 17, 2017 | Volume: 28 | Issue: 1 | Pages: 59-62

10.1111/pan.13283 | PMID 29148179 Get It

SummaryBackgroundDe Barsy syndrome is a rare, autosomal recessive syndrome characterized by cutis laxa, progeroid appearance, ophthalmic opacification, skeletal malformations, growth delays, and intellectual disability.AimsThe aim of this case series is to identify the anesthetic considerations in the clinical management of patients with de Barsy syndrome.MethodsA retrospective case review from 1968 to 2016 was performed at a single tertiary medical center to identify patients with de Barsy syndrome who underwent anesthesia for diagnostic and surgical procedures. We collected and analyzed the perioperative records and following data: age, sex, American Society of Anesthesiologists physical status, relevant comorbidities, surgical procedures, anesthesia management, and observed complications.ResultsThree patients underwent 64 unique anesthetics for a diverse collection of diagnostic and surgical procedures. An array of anesthetics and techniques were successfully used. Observations of the perioperative period found 7 episodes of intraoperative hyperthermia (>38.3°), a single difficult airway requiring fiberoptic bronchoscopic‐guided intubation, and repeatedly difficult intravenous access.ConclusionThis expanded case series suggests that providers caring for patients with de Barsy syndrome should be aware of potential challenges with airway management, vascular access, and temperature monitoring.
Utility of multimodal analgesia with fascia iliaca blockade for acute pain management following hip arthroscopy
Krych, Aaron J. , Baran, Sean, Kuzma, Scott A., Smith, Hugh M. , Levy, Bruce A. , Johnson, Rebecca L. , Krych, Aaron J

Mayo Clinic

Knee Surgery, Sports Traumatology, Arthroscopy | September 23, 2013 | Volume: 22 | Issue: 4 | Pages: 843-847

10.1007/s00167-013-2665-y | PMID 24061718 Get It

AbstractPurposeThe purpose of this study was to evaluate the utility of multimodal analgesia with fascia iliaca blockade and for acute pain control in patients undergoing hip arthroscopy.MethodsThirty consecutive patients undergoing primary hip arthroscopy were prospectively studied. All patients were treated preoperatively with ultrasound‐guided single injection fascia iliaca blockade and multimodal analgesia. Data collected included post‐operative nausea, numeric rating scale (NRS) pain scores during rest and activity, opioid consumption during the first five days (recorded as tablets of 5 mg hydrocodone/500 mg acetaminophen) and overall patient satisfaction with analgesia.ResultsThis study included 23 female and 7 male patients with a median age of 35 years (range 14–58). No patient required medication for post‐operative nausea. The overall NRS scores were an average of 3.9 on day 0, 3.6 on day 1, 3.4 on day 2, 2.9 on day 3, 3.0 on day 4 and 2.7 on day 5. The average tablets of opioid taken were 1.5 on day 0, 1.2 on day 1, 1.3 on day 2, 1.0 on day 3, 1.1 on day 4 and 0.9 on day 5. Overall, 20 patients rated their post‐operative pain control as very satisfied (67 %), and 10 patients as satisfied (33 %). There were no complications or side effects from the fascia iliaca blockade.ConclusionIn this prospective study, multimodal analgesia with fascia iliaca blockade following hip arthroscopy was safe and effective. The quality of early post‐operative analgesia provided by the fascia iliaca blockade was excellent and resulted in low opioid consumption, high quality of pain relief and high overall patient satisfaction.Level of evidenceProspective case series, Level II.